Purpose Studies reporting male breast cancer outcomes in Australia are rare. This study sought to determine the feasibility of a retrospective audit of male breast cancer cases compared to matched females within a tertiary hospital. Methodology Following HREC and institutional approvals, a retrospective audit of breast cancer patients treated within the Lyell McEwin Health Service (SA) between 2009 and 2023 was completed. Male to female case matching was in a ratio of 1:2 based upon year of diagnosis and age. Records were extracted for patient demographic, tumour, treatment and follow-up information. Descriptive statistics and non-parametric testing were employed in the analysis. Results Ten male breast cancer cases combined with twenty matched females were retrieved. Male cancers presented as a unilateral breast mass and were luminal A/B subtypes of ductal carcinomas. Sonographic features favoured a round circumscribed mass (P = 0.029), compared to matched females. Mastectomy and axillary clearance was the primary male surgical modality. No significant differences were found in clinical stage or adjuvant therapy utilisation between the patient groups. Four deaths were recorded during median follow up of 52 months (IQR 61.5). A single male death was attributable to breast cancer. Kaplan Meier survival analysis was not performed due to low event rate. Conclusion Male breast cancers differed in presentation, imaging features, tumour characteristics and surgical treatment compared to females. Adjuvant therapy prescription met ASCO guidelines targets. A broader multi-institutional study of male breast cancer outcomes remains a viable approach in improving knowledge of this rare cancer.